Zantrene Shows Impressive Synergy With BRAF & MEK Inhibitors In Treating Melanoma

Race Oncology Limited shared the final results from our preclinical melanoma research program in collaboration with the University of Newcastle
[Race Oncology Ltd]
Press Release
spot_img

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News